NERA's Global Health Care Practice covers the full range of litigation, regulatory/reform, public policy, and business strategy questions that arise in this complex industry. Our health economists have analyzed hundreds of mergers involving hospitals, health insurers, physicians, pharmaceuticals, and medical device companies. Many of these mergers have been reviewed by both US and European antitrust authorities. Our litigation experience covers antitrust issues such as monopolization, price fixing, unfair methods of competition, exclusive dealing, and other vertical restraints issues, such as those posed by integrated health care systems.
NERA also has extensive experience in patent valuation and litigation relating to various medical devices and processes. In the area of public policy, our economists in the US and Europe have worked with governments as well as purchasers and providers of health care around the world to create competitive markets, develop alternative administrative strategies, and enact realistic health care reforms that can improve both the efficiency and the fairness of health systems around the world. We have also analyzed such topics as intellectual property protection, parallel trade of pharmaceuticals, and health care. Our work has been used by organizations such as the European Commission, World Trade Organization, and US Trade Representatives to improve the environment for pharmaceutical research and development.
